| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |